Cross-link

Crosslink Capital Leads Airvine $6.2M Series A Extension Aimed at Acceleration of WaveTunnel Product Roadmap

Retrieved on: 
Monday, March 25, 2024
Principal, Cross-link, LAN, Series, Crosslink Capital

SANTA CLARA, Calif., March 25, 2024 /PRNewswire/ -- Airvine, the first company to develop a multi-Gigabit-speed wireless backhaul system for indoor connectivity, today announced the close of its Series A funding round.  Crosslink Capital of Menlo Park, CA led the round, which totaled $6.2M and closed at the end of February.  Airvine will use the funding for ongoing product development and to expand the sales team in order to take advantage of increased interest from customers in the company's target markets.

Key Points: 
  • Crosslink Capital of Menlo Park, CA led the round, which totaled $6.2M and closed at the end of February.
  • Airvine will use the funding for ongoing product development and to expand the sales team in order to take advantage of increased interest from customers in the company's target markets.
  • "Crosslink Capital sees an excellent investment opportunity."
  • - Michael Stark, Principal of Crosslink Capital
    "Crosslink Capital sees an excellent investment opportunity in helping the WaveTunnel product reach its full potential with deployments in a variety of exciting new network applications," said Michael Stark, Principal of Crosslink Capital.

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Retrieved on: 
Wednesday, January 24, 2024
System, Death, Allergy, Heron, Patient, Vitamin, Naproxen, Elective surgery, SAN, Health, Partnership, Foot, Gastrointestinal bleeding, Ibuprofen, Vomiting, Anemia, Ankle, Stroke, Heart failure, Medicine, Nonsteroidal anti-inflammatory drug, Patient satisfaction, Cartilage, Risk, Meloxicam, Pain, VAN, Cross-link, Food, Constipation, Pregnancy, NDA, Anesthetic, Aspirin, Tears, FDA, Ulcer, Liver, Boxed warning, New Drug Application, Headache, Bupivacaine, Human, Blood, Pharmaceutical industry

SAN DIEGO, Jan. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (the "FDA") has approved its supplemental New Drug Application ("NDA") for ZYNRELEF® (bupivacaine and meloxicam) extended-release solution to expand the indication for soft tissue and orthopedic surgical procedures including foot and ankle, and other procedures in which direct exposure to articular cartilage is avoided. ZYNRELEF was previously approved for foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures in adults.

Key Points: 
  • ZYNRELEF was previously approved for foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures in adults.
  • This expanded indication for ZYNRELEF will now cover an estimated 13 million procedures annually, an estimated increase of 86% over prior indicated procedures.
  • To obtain this labeling expansion, Heron successfully conducted studies for cesarean section, spinal surgery, augmentation mammoplasty, and total shoulder arthroplasty.
  • The most common side effects of ZYNRELEF are soft tissue procedures: vomiting and orthopedic procedures: constipation and headache.

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Retrieved on: 
Sunday, January 7, 2024
Partnership, Heron, Meloxicam, SAN, Therapy, Spine, Growth, Bupivacaine, Patient, Cross-link, VAN, Nursing

The partnership will launch in several phases, initially at a regional level, followed by an expanded national rollout.

Key Points: 
  • The partnership will launch in several phases, initially at a regional level, followed by an expanded national rollout.
  • In total, approximately 650 representatives will be added to Heron's sales network over the next year.
  • CrossLink will be the lead partner in the United States to expand ZYNRELEF promotion for orthopedic indications.
  • "CrossLink has a proven track record of success in building relationships, providing superior service to healthcare providers and improving patient outcomes.

Darkhive Inc. Closes $4M Seed Round to Scale Development of Low-cost Autonomous Drones for Defense and Public Safety

Retrieved on: 
Thursday, November 30, 2023
Stellar, Citizenship, Crosslink Capital, Defense, Department of Defence, SAN, Cross-link

This round of financing will enable Darkhive to accelerate production of both hardware and software product lines in support of high-profile Department of Defense initiatives.

Key Points: 
  • This round of financing will enable Darkhive to accelerate production of both hardware and software product lines in support of high-profile Department of Defense initiatives.
  • Matt Bigge, Partner at Crosslink Capital and Darkhive Board Member, commented "Darkhive represents the future of uncrewed systems.
  • Their open hardware and software architecture enables the first truly scalable, interoperable and cost appropriate approach to US-made drones.
  • Crosslink is excited to work with the Darkhive team to facilitate this strategic architectural approach at a critical time for US National Security."

Keysight Enabling University of Stuttgart to Advance 6G Integrated Circuits Research

Retrieved on: 
Tuesday, August 8, 2023
Technology, Mobile, Wireless, Research, Semiconductor, Software, Hardware, University, Science, Education, Hertz, Communication, University of Stuttgart Library, DFG, AWG, VDI, ICS, University of Stuttgart, VSA, VCA, VNA, Terahertz, Digital technology, German, German Research Foundation, Next Generation, NYSE, Cross-link, Cable television, Mobile phone, Keysight

Keysight Technologies, Inc. (NYSE: KEYS) is enabling the University of Stuttgart to conduct foundational research essential to development of new integrated circuits (ICs) for 6G technology with the new Keysight 6G Vector Component Analysis (VCA) solution .

Key Points: 
  • Keysight Technologies, Inc. (NYSE: KEYS) is enabling the University of Stuttgart to conduct foundational research essential to development of new integrated circuits (ICs) for 6G technology with the new Keysight 6G Vector Component Analysis (VCA) solution .
  • This is the latest collaboration from Keysight and the University of Stuttgart’s long-time research relationship.
  • The collaboration has supported the University of Stuttgart in establishing Crosslink, a versatile multiplexing platform for synchronous time- and frequency-domain analyses of ultra-broadband communication channels.
  • The Keysight and University of Stuttgart collaboration supports a large-scale equipment initiative funded by the German Research Foundation (DFG).

CrossLink Professional Tax Solutions (CPTS) Announces the Acquisition of uTax Software

Retrieved on: 
Friday, July 7, 2023
EMP, Acquisition, Cross-link, Entrepreneurship, Service bureau, Property management, Video game

ORLANDO, Fla., July 7, 2023 /PRNewswire/ -- CrossLink Professional Tax Solutions ("CPTS", "CrossLink", or the "Company"), a leading provider of professional tax software solutions to professional tax preparers across the United States, announced today the acquisition of uTax Software, LLC ("uTax").

Key Points: 
  • ORLANDO, Fla., July 7, 2023 /PRNewswire/ -- CrossLink Professional Tax Solutions ("CPTS", "CrossLink", or the "Company"), a leading provider of professional tax software solutions to professional tax preparers across the United States, announced today the acquisition of uTax Software, LLC ("uTax").
  • CrossLink Professional Tax Solutions (CPTS) Announces the Acquisition of uTax Software.
  • "uTax has established themselves as a leading Service Bureau in the professional tax preparation marketplace," stated Reynold Sbrilli, CPTS CEO.
  • Dan Beckler, Co-Founder of uTax Software, LLC, commented, "The synergies between CrossLink and uTax made this a natural fit that benefits our partners.

SightMD Physicians named 2023 Super Doctors® and Rising Stars

Retrieved on: 
Monday, May 15, 2023
Medicine, Editorial board, Paratriathlon, DO, MD, Patient, Premature, Neuro-ophthalmology, Forehead, World Golf Village, Corneal transplantation, Face, Friends, Orbit, Research, Rockville Centre, New York, Super, Uveitis, Optic nerve, Entrepreneurship, New York Eye and Ear Infirmary, Textbook, Cataract, Abstract, Osteopathic medicine in the United States, Good Samaritan Hospital, Eye, Eyelid, Publishing, Clinical research, Engineering, Microsurgery, Family, Surgeon, CXL, Education, Cross-link, Physician, Hall, Fellow, Pleasure, Rare-earth element, Medical device, Nursing, Dentistry, Veterinary medicine, Ophthalmology, Glaucoma, PRK, Retina, LASIK

HAUPPAUGE, N.Y., May 15, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.

Key Points: 
  • SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.
  • HAUPPAUGE, N.Y., May 15, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.
  • said Dr. Baharestani "It is an honor to provide our patients with the highest level oculoplastic surgery services at SightMD."
  • "I am truly honored to be selected as a Super Doctors Rising Star for the 5th year in a row."

PayJunction Enhances Developer Tech Stack to Streamline Integrated ACH Payment Acceptance

Retrieved on: 
Tuesday, February 21, 2023
A2A, Virtual terminal, ACH, Cross-link, Wallet, API, Software, Online shopping, Bank, Cryptocurrency, Plaid

SANTA BARBARA, Calif., Feb. 21, 2023 /PRNewswire-PRWeb/ -- PayJunction, a leading developer of payment processing technology, has enhanced its developer toolset to allow software companies to integrate advanced Account-to-Account (A2A) bank transfer connectivity within their platforms. Transactions are routed via the PayJunction gateway using low-cost ACH processing rails, which results in significant savings for businesses.

Key Points: 
  • Transactions are routed via the PayJunction gateway using low-cost ACH processing rails, which results in significant savings for businesses.
  • PayJunction recently added secure A2A functionality from Plaid , which simplifies the enrollment and identification processes associated with ACH account setup.
  • CrossLink Professional Tax Solutions has integrated this enhanced ACH functionality into their professional tax software solutions to allow tax preparers to extend pay-by-bank capabilities to their clients.
  • Plaid's connectivity technology can quickly and easily be integrated with software applications via a simple plug-in using PayJunction's intuitive API and developer tools .

CLAP introduces Organic Thin Film Transistor (OTFT) application technology at CES 2023

Retrieved on: 
Friday, January 6, 2023
MicroLED, RIE, Electronics, OTFT, CES, TFT, OPD, Information technology, Exhibition, Flexible electronics, CLAP, BASF, OLED, Carbon, IOT, Consumer electronics, Electronic component, Printed circuit board, Cross-link, Flexible

SEOUL, South Korea, Jan. 6, 2023 /PRNewswire/ -- CLAP (CEO Sungho Kim, www.clap.co.kr ), a company specializing in materials and parts for organic semiconductors and displays, participates in CES 2023, the world's largest consumer electronics and information technology exhibition from January 5th to 8th.

Key Points: 
  • SEOUL, South Korea, Jan. 6, 2023 /PRNewswire/ -- CLAP (CEO Sungho Kim, www.clap.co.kr ), a company specializing in materials and parts for organic semiconductors and displays, participates in CES 2023, the world's largest consumer electronics and information technology exhibition from January 5th to 8th.
  • At CES 2023, CLAP prepares an exhibition booth in the IoT Infrastructure Sector (Korea Sensor Pavilion, Booth No.
  • After acquiring OTFT material patents and technologies from Germany's BASF, CLAP has its own organic semiconductor research fab and is actively developing application products.
  • It will further promote technology through participation in CES 2023 exhibition and expand cooperative partnerships with global companies.

CLAP introduces Organic Thin Film Transistor (OTFT) application technology at CES 2023

Retrieved on: 
Thursday, January 5, 2023
MicroLED, RIE, Electronics, OTFT, CES, TFT, Multimedia, OPD, Information technology, Exhibition, Flexible electronics, CLAP, BASF, OLED, Carbon, IOT, Consumer electronics, Electronic component, Printed circuit board, Cross-link, Flexible

SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- CLAP (CEO Sungho Kim, www.clap.co.kr ), a company specializing in materials and parts for organic semiconductors and displays, participates in CES 2023, the world's largest consumer electronics and information technology exhibition from January 5th to 8th.

Key Points: 
  • SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- CLAP (CEO Sungho Kim, www.clap.co.kr ), a company specializing in materials and parts for organic semiconductors and displays, participates in CES 2023, the world's largest consumer electronics and information technology exhibition from January 5th to 8th.
  • At CES 2023, CLAP prepares an exhibition booth in the IoT Infrastructure Sector (Korea Sensor Pavilion, Booth No.
  • After acquiring OTFT material patents and technologies from Germany's BASF, CLAP has its own organic semiconductor research fab and is actively developing application products.
  • It will further promote technology through participation in CES 2023 exhibition and expand cooperative partnerships with global companies.